Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

[1]  T. Buclin,et al.  Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study , 2018, The Journal of antimicrobial chemotherapy.

[2]  S. Gordon,et al.  Emergency department visits during outpatient parenteral antimicrobial therapy: a retrospective cohort study , 2018, The Journal of antimicrobial chemotherapy.

[3]  I. Okeke,et al.  Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure , 2018, The Journal of antimicrobial chemotherapy.

[4]  J. Rangaiah,et al.  Continuous beta-lactam intravenous antibiotic infusions for outpatient parenteral antimicrobial therapy. , 2018, International Journal of Antimicrobial Agents.

[5]  G. Rao,et al.  Incidence and risk factors for healthcare utilisation among patients discharged on outpatient parenteral antimicrobial therapy , 2018, Epidemiology and Infection.

[6]  Eileen J. Carter,et al.  Exploring the Role of the Bedside Nurse in Antimicrobial Stewardship: Survey Results From Five Acute-Care Hospitals , 2018, Infection Control & Hospital Epidemiology.

[7]  R. Kayyali,et al.  Evaluation of the performance of elastomeric pumps in practice: are we under-delivering on chemotherapy treatments? , 2017, Current medical research and opinion.

[8]  C. Chidiac,et al.  Outpatient parenteral antibiotic therapy: Evaluation of practices and limits of use in rural areas in France. , 2017, Médecine et maladies infectieuses.

[9]  J. Sluggett,et al.  Safety of continuous antibiotic infusions administered through an Australian hospital in the home service: a pilot study , 2017 .

[10]  D. McQuillen,et al.  The Value That Infectious Diseases Physicians Bring to the Healthcare System , 2017, The Journal of infectious diseases.

[11]  P. Dobson,et al.  Determining the Risk of Sepsis Using Nurse-Compounded Elastomeric Pumps for Continuous Infusion in Outpatient Parenteral Antibiotic Therapy , 2017, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[12]  T. Buclin,et al.  Adequate plasma drug concentrations suggest that amoxicillin can be administered by continuous infusion using elastomeric pumps , 2017, The Journal of antimicrobial chemotherapy.

[13]  K. Wilby,et al.  A Systematic Review of Antimicrobial Stewardship Interventions in the Emergency Department , 2017, The Annals of pharmacotherapy.

[14]  T. Buclin,et al.  Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT) , 2017, The Journal of antimicrobial chemotherapy.

[15]  M. Gilchrist,et al.  Extended stability of antimicrobial agents in administration devices , 2017, The Journal of antimicrobial chemotherapy.

[16]  S. Hess,et al.  The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy , 2017 .

[17]  Christopher D Miller,et al.  Characterization of Drug-Related Problems Occurring in Patients Receiving Outpatient Antimicrobial Therapy , 2017, Journal of pharmacy practice.

[18]  C. Welch,et al.  The utility of a blood culture database to identify patients suitable for outpatient parenteral antibiotic treatment , 2016, Postgraduate Medical Journal.

[19]  R. Bellomo,et al.  Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials. , 2016, American journal of respiratory and critical care medicine.

[20]  A. Kimmoun,et al.  The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  Margaret A Dudeck,et al.  Antibiotic Stewardship Programs in U.S. Acute Care Hospitals: Findings From the 2014 National Healthcare Safety Network Annual Hospital Survey. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  C. Pattyn,et al.  Optimization of a model of out-of-hospital antibiotic therapy (OPAT) in a Belgian university hospital resulting in a proposal for national implementation , 2016, Acta clinica Belgica.

[23]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. J. Candel,et al.  Current status in outpatient parenteral antimicrobial therapy: a practical view. , 2016, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[25]  C. Gardiol,et al.  Setting up an outpatient parenteral antimicrobial therapy (OPAT) unit in Switzerland: review of the first 18 months of activity , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[26]  R. Bellomo,et al.  A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. , 2015, American journal of respiratory and critical care medicine.

[27]  A. Bolger,et al.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association , 2015, Circulation.

[28]  D. Graham,et al.  Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit , 2015, Journal of pharmacy practice.

[29]  David N. Williams,et al.  The history and evolution of outpatient parenteral antibiotic therapy (OPAT). , 2015, International journal of antimicrobial agents.

[30]  S. Corman,et al.  Implementing criteria-based early switch/early discharge programmes: a European perspective. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  A. Chapman,et al.  Clostridium difficile infection following outpatient parenteral antimicrobial therapy. , 2015, Journal of Hospital Infection.

[32]  Daniel L. Brown,et al.  The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion , 2015, Journal of clinical pharmacy and therapeutics.

[33]  M. Samore,et al.  Evaluation of Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Hospital , 2015, Infection Control & Hospital Epidemiology.

[34]  K. Switkowski,et al.  A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT) , 2015, Infectious diseases.

[35]  M. Gilchrist,et al.  Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. , 2014, The Journal of antimicrobial chemotherapy.

[36]  S. Erdman,et al.  Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases. , 2014, The Journal of antimicrobial chemotherapy.

[37]  P. Polgreen,et al.  Outpatient Parenteral Antimicrobial Therapy Practices among Adult Infectious Disease Physicians , 2014, Infection Control & Hospital Epidemiology.

[38]  A. Kwa,et al.  Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis. , 2014, International journal of antimicrobial agents.

[39]  G. Allison,et al.  Are we ready for an outpatient parenteral antimicrobial therapy bundle? A critical appraisal of the evidence. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  J. Decruyenaere,et al.  A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[41]  I. Spriet,et al.  STIMULATION OF THE IV TO ORAL SWITCH OF BIOAVAILABLE DRUGS BY PHONE CALLS IN A BELGIAN TERTIARY CARE HOSPITAL , 2013 .

[42]  C. Winnard,et al.  Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. , 2012, The Journal of antimicrobial chemotherapy.

[43]  D. Nicolau,et al.  Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator‐Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback , 2012, Pharmacotherapy.

[44]  S. Gordon,et al.  Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy. , 2012, Journal of hospital medicine.

[45]  D. Nathwani,et al.  Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. , 2012, The Journal of antimicrobial chemotherapy.

[46]  R. Seaton,et al.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review , 2012, International Journal of Clinical Pharmacy.

[47]  D. Paterson,et al.  New Gram-positive antibiotics: better than vancomycin? , 2011, Current opinion in infectious diseases.

[48]  Brett H. Heintz,et al.  Impact of a Multidisciplinary Team Review of Potential Outpatient Parenteral Antimicrobial Therapy Prior to Discharge from an Academic Medical Center , 2011, The Annals of pharmacotherapy.

[49]  P. Tamma,et al.  Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials , 2011, BMC infectious diseases.

[50]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  J. Paladino,et al.  Outpatient parenteral antimicrobial therapy today. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  A. G. Ellis,et al.  Stability of Intravenous Flucloxacillin Solutions used for Hospital‐in‐the‐Home , 2010 .

[53]  P. Tulkens,et al.  Stability of meropenem and doripenem solutions for administration by continuous infusion. , 2010, The Journal of antimicrobial chemotherapy.

[54]  Joshua D. Courter,et al.  Optimizing bactericidal exposure for β‐lactams using prolonged and continuous infusions in the pediatric population , 2009, Pediatric blood & cancer.

[55]  D. Levine,et al.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  M. Roberts,et al.  Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. , 2009, The Journal of antimicrobial chemotherapy.

[57]  Francis Remerand,et al.  Elastomeric Pump Reliability in Postoperative Regional Anesthesia: A Survey of 430 Consecutive Devices , 2008, Anesthesia and analgesia.

[58]  B. Franklin,et al.  An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. , 2008, The Journal of antimicrobial chemotherapy.

[59]  P. Bonnabry,et al.  Evaluation of the design and reliability of three elastomeric and one mechanical infusers , 2007, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[60]  G. Drusano,et al.  Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  Lawrence P. Martinelli,et al.  Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  J. Davis,et al.  Management of bone and joint infections due to Staphylococcus aureus , 2005, Internal medicine journal.

[63]  R. Sharma,et al.  Impact of Mandatory Inpatient Infectious Disease Consultation on Outpatient Parenteral Antibiotic Therapy , 2005, The American journal of the medical sciences.

[64]  John S. Bradley,et al.  Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy , 2004 .

[65]  B. Currie,et al.  Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters , 2004, Tropical medicine & international health : TM & IH.

[66]  W. Craig.  Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. , 2003, Infectious disease clinics of North America.

[67]  P. Tulkens,et al.  Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. , 2003, The Journal of antimicrobial chemotherapy.

[68]  P. Tulkens,et al.  Comparative Stability Studies of Antipseudomonal β-Lactams for Potential Administration through Portable Elastomeric Pumps (Home Therapy for Cystic Fibrosis Patients) and Motor-Operated Syringes (Intensive Care Units) , 2002, Antimicrobial Agents and Chemotherapy.

[69]  P. Tulkens,et al.  Stability and Compatibility of Ceftazidime Administered by Continuous Infusion to Intensive Care Patients , 2001, Antimicrobial Agents and Chemotherapy.

[70]  M. Richards,et al.  The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. , 2001, The Journal of antimicrobial chemotherapy.

[71]  L. Rice,et al.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.

[72]  Jing-jing Hao,et al.  Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis. , 2016, International journal of antimicrobial agents.

[73]  J. Castillo,et al.  Situación actual del tratamiento antimicrobiano domiciliario endovenoso: una visión práctica , 2016 .

[74]  C. Beckwith,et al.  Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island. , 2014, Rhode Island medical journal.

[75]  D. Nathwani,et al.  Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade. , 2014, International journal of antimicrobial agents.

[76]  Amy S Nowacki,et al.  Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. , 2014, The Journal of antimicrobial chemotherapy.

[77]  Jason E. Bowling,et al.  Outpatient Parenteral Antimicrobial Therapy , 2013 .

[78]  A. Hanssen,et al.  Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  D. Osmon,et al.  Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections. , 2012, Mayo Clinic proceedings.

[80]  E. V. van Maarseveen,et al.  [Continuous and intermittent infusion of vancomycin equally effective: review of the literature]. , 2011, Nederlands tijdschrift voor geneeskunde.

[81]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  Donald R Graham,et al.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.